[1]
2025. Association between Interleukin-6 Levels, Rituximab Response, and Disease Activity in Patients with Rheumatoid Arthritis. Al Mustansiriyah Journal of Pharmaceutical Sciences. 25, 3 (Aug. 2025), 455–461. DOI:https://doi.org/10.32947/ajps.v25i3.1225.